California's November cannabis enforcement operations represent one of the most significant crackdowns on illegal cultivation in recent months, with state officials seizing 58,358 illegal cannabis plants and nearly three tons of processed cannabis valued at approximately $56.5 million. These coordinated raids across Alameda and Los Angeles counties underscore the persistent challenge illicit markets pose to […]
President Trump's indication that he will reclassify marijuana from Schedule I to Schedule III represents the most significant federal cannabis policy shift in decades. This potential change would move marijuana from the same legal category as heroin to classification alongside steroids and ketamine, fundamentally altering the compliance and operational framework for cannabis businesses across the […]
A Rockford city council member is pushing for local restrictions on 7-hydroxymitragynine (7-OH), a controversial chemical compound derived from kratom that has been linked to overdose deaths and prompted federal scrutiny. Alderman Tim Durkee's proposed ban cleared the city's code and regulation committee by a 3-2 vote on November 11, 2025, and now awaits a […]
The Natchitoches Parish Sheriff's Impact Unit marked a significant milestone in their ongoing crimefighting initiative with three arrests on November 7, 2025, including charges related to kratom possession. The arrests highlight Louisiana's unique legal classification of kratom as a Schedule I narcotic, a designation that sets the state apart from most of the nation where […]
A new U.S. Supreme Court decision is sending a clear message to cannabis, CBD, and hemp businesses: product claims, testing practices, and quality controls are now firmly under the national compliance microscope. In Medical Marijuana, Inc. et al v. Horn (2025), the Court ruled that a fired truck driver can sue CBD manufacturers under the […]
As the late, great Yogi Berra famously quipped, “It’s déjà vu all over again.” That phrase perfectly captures what I’m seeing today in the CBD industry, a regulatory and enforcement landscape that feels eerily reminiscent of my experience in the mortgage sector during the post-crisis crackdown. Back in my mortgage industry days, I watched firsthand […]
The U.S. Senate has rejected an amendment that would have removed sweeping hemp THC ban language from a key government spending bill, signaling that federal recriminalization of many hemp-derived products is moving forward. The vote deepens uncertainty for hemp businesses and accelerates the need for rigorous compliance, documentation, and risk planning. What the Senate Just […]
A bipartisan coalition of 39 state and territory attorneys general has called on Congress to eliminate the legal pathway that enabled the intoxicating hemp product market. The coalition delivered a letter to key appropriations and agriculture committee leaders requesting federal clarification that would effectively shut down the multi-billion dollar hemp-derived THC industry. Farm Bill Loophole […]
The Food and Drug Administration reversed its position on nicotinamide mononucleotide (NMN) supplement sales, acknowledging the ingredient was on the market prior to being studied as an investigational new drug. The decision, reported by Nutrition Business Journal, opens the door for continued NMN supplement sales while generating divergent reactions from supplement industry trade associations. The […]
A legal challenge filed by dietary supplement manufacturer Xlear against the Federal Trade Commission could fundamentally reshape how companies market health products in the United States. The lawsuit, reported by KFF Health News, seeks to eliminate the FTC's longstanding requirement that companies provide substantial evidence backing health claims about their products—a standard maintained since 1984. […]
